🚀 Years Of Research At Navaux Begins To Redefine Hepsin's Role In Cancer Genesis 🚀 At Navaux, we’re on a mission to revolutionize cancer detection with our cutting-edge research in non-invasive early detection. We’re thrilled to share a major breakthrough in our work with serine proteases, particularly hepsin. While many have explored hepsin before, our team has uncovered critical differences between full-length hepsin and circulating, activated hepsin—insights that had eluded others. This discovery is a significant step forward in understanding cancer biomarkers and improving early detection methods. We’re proud to announce that we’ve completed epitope mapping and filed patents for our innovative findings related to hepsin. This advancement brings us closer to transforming how cancer is detected and treated, ultimately paving the way for better patient outcomes. A huge thank you to our dedicated team for their hard work and perseverance. We’re excited about the future and the potential impact of our discoveries! 🔬💡 Stay tuned for more updates as we continue to advance the field of cancer research. hashtag #CancerResearch hashtag #Innovation hashtag #EarlyDetection hashtag #Hepsin hashtag #Navaux hashtag #MedicalBreakthrough hashtag #Biotech
Navaux
Biotechnology Research
Little Rock, Arkansas 244 followers
Better Health Outcomes Beyond Diagnostics
About us
Navaux, Inc. is building upon proprietary technology to provide cancer patients and their physicians with direction beyond diagnostics. Through our pipeline of novel proteins we are not only able to detect cancer in it earliest form but we are using this same technology to aid in treatment monitoring and ultimately targeted drug delivery. We understand the "cancer cascade" that occurs when cells seemingly experience uncontrolled growth. By developing non-invasive blood tests to measure proteins that are both capable and active in cancer progression, we can identify, target and potentially deliver therapies to the tumors at their earliest stage.
- Website
-
http://www.navaux.com
External link for Navaux
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Little Rock, Arkansas
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Cancer Diagnostics, Cancer Therapeutics, and Targeted Drug Delivery
Locations
-
Primary
Get directions
10912 Colonel Glenn Rd
Little Rock, Arkansas 72204, US